🇺🇸 Transdermal Buprenorphine in United States

Transdermal Buprenorphine (Transdermal Buprenorphine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Transdermal Buprenorphine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Transdermal Buprenorphine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Transdermal Buprenorphine in United States?

Taiwan Mundipharma Pharmaceuticals Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.